CNBC's Jim Cramer noted a shift in his stance on Bunge Global SA, a major agricultural commodities processor, despite its recent strong performance. Analysts are weighing the stock's future trajectory amid broader market volatility and sector-specific headwinds.
CNBC's Jim Cramer acknowledged Moderna's strong January performance but expressed caution, noting the company faces years of unprofitability and highlighting other pharmaceutical and biotech stocks he finds more attractive for investment.
While Nordson Corporation may not be chasing explosive growth, its consistent 14% return on capital employed and disciplined reinvestment strategy have delivered solid, long-term value for shareholders. We analyze the stability behind the industrial technology leader's performance.
The medtech giant surpassed financial expectations, driven by robust performance in its core imaging and pharmaceutical diagnostics segments, while outlining a strategic shift towards becoming a comprehensive healthcare solutions provider.
Spire Inc. posted a sharp rise in fiscal first-quarter earnings, driven by higher natural gas rates and improved utility performance. The company reaffirmed its full-year outlook, signaling confidence amid regulatory adjustments and evolving energy market dynamics.
With units trading near $20, Suburban Propane Partners (SPH) presents a conundrum for investors. While recent performance has been mixed, a detailed cash flow and earnings analysis suggests the stock may be significantly undervalued. We examine the metrics behind the potential discount and what it means for the propane distributor's outlook.
Catalyst Brands, the North American operator of the century-old outdoor apparel chain Eddie Bauer, is preparing for a Chapter 11 bankruptcy filing, a move expected to shutter its physical stores across the U.S. and Canada, including multiple locations in Ohio.
As online ad costs surge, a technical revolution in user consent, pioneered in Europe, is quietly reshaping the global ad landscape. U.S. businesses, already grappling with state privacy laws, must integrate compliance with campaign performance to safeguard future marketing efficacy.
GSK delivered a robust fourth-quarter performance, surpassing its medium-term targets ahead of schedule. However, the company's deliberately conservative guidance for 2026 has left the market debating whether this signals prudent management or a missed opportunity to inspire greater confidence.
The landmark $100 billion infrastructure partnership between OpenAI and Nvidia has failed to materialize into a binding agreement, exposing underlying tensions over chip supply and performance demands, and raising broader concerns about speculative dynamics in the AI sector.
Shares of Columbia Sportswear (COLM) soared over 13% after the outdoor apparel giant posted better-than-expected Q4 results and issued an optimistic full-year profit forecast, signaling a potential turnaround after a period of market skepticism.
Despite posting quarterly results that exceeded analyst expectations, shares of Boston Scientific and AbbVie fell sharply as investors scrutinized underperformance in key business units and expressed caution over forward-looking statements.
Medical apparel brand FIGS extends its role as official outfitter for Team USA's medical staff through the 2028 Games, launching a new campaign with Olympian Lindsey Vonn. The move aims to solidify its brand identity with healthcare professionals on a global stage.
Automotive seating giant Adient plc kicked off its fiscal 2026 with a resilient performance, overcoming supply chain disruptions to post a 4% revenue increase. The company raised its annual guidance, citing a robust pipeline of onshoring opportunities in the Americas and strong growth in China.
Uber's logistics arm, Uber Freight, achieved breakeven profitability for the first time in over three years during Q4, a notable feat against a backdrop of flat revenue and a challenging trucking market. This milestone comes as Uber's overall platform delivered record-breaking profits, highlighting a diverging performance within the tech giant's portfolio.
Alphabet (GOOGL) reports Q4 2025 earnings after the bell, with Wall Street anticipating strong growth. All eyes are on Google Cloud's profitability as investors weigh massive AI investments against the tech giant's historic margin performance.
Packaging leader Silgan Holdings reports robust 2025 results, driven by record performance in dispensing closures and pet food containers. With key leadership changes and the Vayner acquisition fully integrated, the company outlines a confident, if cautious, outlook for 2026 amid evolving consumer trends.
Shares of Perfect Corp. (PERF) have tumbled over 33% in the past year, trading near $1.46. While recent performance has spooked investors, a deep dive into valuation metrics suggests the software company may be significantly undervalued. We examine the numbers and the narratives shaping this volatile stock.
Royal Philips is spearheading a significant European Union-backed consortium, PreciseOnco, aimed at advancing precision oncology through next-generation imaging and minimally invasive therapies. The move comes as the healthcare giant's stock performance draws mixed reviews from the market.
As copper prices surge to unprecedented levels, mining giant Freeport-McMoRan (NYSE: FCX) reports robust financial performance, linking its strategy to long-term electrification demand while maintaining a disciplined approach to growth and shareholder returns.
